The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Human Tissue Chips Market Research Report 2024

Global Human Tissue Chips Market Research Report 2024

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1747836

No of Pages : 106

Synopsis
Human Tissue Chips (HTCs) are a type of organ-on-a-chip technology and involve the use of human cells arranged on small chips or plates, which replicate the function of human organs and tissues.
Global Human Tissue Chips market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Human Tissue Chips market research.
HTCs have many advantages over traditional animal models, such as greater efficiency and reduced costs, reduced animal use, and a more precise representation of human physiology. They are a promising new technology that may revolutionize the way we conduct biomedical research and drug development.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Human Tissue Chips market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Emulate, Inc.
CN Bio Innovations Ltd.
TissUse GmbH
InSphero AG
HµRel Corporation
AxoSim Technologies LLC
Kugelmeiers Ltd.
Miroculus Inc.
Mimetas BV
SynVivo Inc.
Advanced BioMatrix Inc.
BIOMIMESYS
Tara Biosystems, Inc.
V&F Bioprocessing, Inc.
Xylyx Bio, Inc.
Segment by Type
Glass Materials
Silicone Materials
Polymers Materials
Segment by Application
Drug Discovery
Toxicity Testing
Disease Modeling
Personalized Medicine
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Human Tissue Chips report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index
1 Human Tissue Chips Market Overview
1.1 Product Overview and Scope of Human Tissue Chips
1.2 Human Tissue Chips Segment by Type
1.2.1 Global Human Tissue Chips Market Value Comparison by Type (2023-2029)
1.2.2 Glass Materials
1.2.3 Silicone Materials
1.2.4 Polymers Materials
1.3 Human Tissue Chips Segment by Application
1.3.1 Global Human Tissue Chips Market Value by Application: (2023-2029)
1.3.2 Drug Discovery
1.3.3 Toxicity Testing
1.3.4 Disease Modeling
1.3.5 Personalized Medicine
1.4 Global Human Tissue Chips Market Size Estimates and Forecasts
1.4.1 Global Human Tissue Chips Revenue 2018-2029
1.4.2 Global Human Tissue Chips Sales 2018-2029
1.4.3 Global Human Tissue Chips Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Human Tissue Chips Market Competition by Manufacturers
2.1 Global Human Tissue Chips Sales Market Share by Manufacturers (2018-2023)
2.2 Global Human Tissue Chips Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Human Tissue Chips Average Price by Manufacturers (2018-2023)
2.4 Global Human Tissue Chips Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Human Tissue Chips, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Tissue Chips, Product Type & Application
2.7 Human Tissue Chips Market Competitive Situation and Trends
2.7.1 Human Tissue Chips Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Tissue Chips Players Market Share by Revenue
2.7.3 Global Human Tissue Chips Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Tissue Chips Retrospective Market Scenario by Region
3.1 Global Human Tissue Chips Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Human Tissue Chips Global Human Tissue Chips Sales by Region: 2018-2029
3.2.1 Global Human Tissue Chips Sales by Region: 2018-2023
3.2.2 Global Human Tissue Chips Sales by Region: 2024-2029
3.3 Global Human Tissue Chips Global Human Tissue Chips Revenue by Region: 2018-2029
3.3.1 Global Human Tissue Chips Revenue by Region: 2018-2023
3.3.2 Global Human Tissue Chips Revenue by Region: 2024-2029
3.4 North America Human Tissue Chips Market Facts & Figures by Country
3.4.1 North America Human Tissue Chips Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Human Tissue Chips Sales by Country (2018-2029)
3.4.3 North America Human Tissue Chips Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Tissue Chips Market Facts & Figures by Country
3.5.1 Europe Human Tissue Chips Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Human Tissue Chips Sales by Country (2018-2029)
3.5.3 Europe Human Tissue Chips Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Tissue Chips Market Facts & Figures by Country
3.6.1 Asia Pacific Human Tissue Chips Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Human Tissue Chips Sales by Country (2018-2029)
3.6.3 Asia Pacific Human Tissue Chips Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Human Tissue Chips Market Facts & Figures by Country
3.7.1 Latin America Human Tissue Chips Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Human Tissue Chips Sales by Country (2018-2029)
3.7.3 Latin America Human Tissue Chips Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Tissue Chips Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Tissue Chips Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Human Tissue Chips Sales by Country (2018-2029)
3.8.3 Middle East and Africa Human Tissue Chips Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Tissue Chips Sales by Type (2018-2029)
4.1.1 Global Human Tissue Chips Sales by Type (2018-2023)
4.1.2 Global Human Tissue Chips Sales by Type (2024-2029)
4.1.3 Global Human Tissue Chips Sales Market Share by Type (2018-2029)
4.2 Global Human Tissue Chips Revenue by Type (2018-2029)
4.2.1 Global Human Tissue Chips Revenue by Type (2018-2023)
4.2.2 Global Human Tissue Chips Revenue by Type (2024-2029)
4.2.3 Global Human Tissue Chips Revenue Market Share by Type (2018-2029)
4.3 Global Human Tissue Chips Price by Type (2018-2029)
5 Segment by Application
5.1 Global Human Tissue Chips Sales by Application (2018-2029)
5.1.1 Global Human Tissue Chips Sales by Application (2018-2023)
5.1.2 Global Human Tissue Chips Sales by Application (2024-2029)
5.1.3 Global Human Tissue Chips Sales Market Share by Application (2018-2029)
5.2 Global Human Tissue Chips Revenue by Application (2018-2029)
5.2.1 Global Human Tissue Chips Revenue by Application (2018-2023)
5.2.2 Global Human Tissue Chips Revenue by Application (2024-2029)
5.2.3 Global Human Tissue Chips Revenue Market Share by Application (2018-2029)
5.3 Global Human Tissue Chips Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Emulate, Inc.
6.1.1 Emulate, Inc. Corporation Information
6.1.2 Emulate, Inc. Description and Business Overview
6.1.3 Emulate, Inc. Human Tissue Chips Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Emulate, Inc. Human Tissue Chips Product Portfolio
6.1.5 Emulate, Inc. Recent Developments/Updates
6.2 CN Bio Innovations Ltd.
6.2.1 CN Bio Innovations Ltd. Corporation Information
6.2.2 CN Bio Innovations Ltd. Description and Business Overview
6.2.3 CN Bio Innovations Ltd. Human Tissue Chips Sales, Revenue and Gross Margin (2018-2023)
6.2.4 CN Bio Innovations Ltd. Human Tissue Chips Product Portfolio
6.2.5 CN Bio Innovations Ltd. Recent Developments/Updates
6.3 TissUse GmbH
6.3.1 TissUse GmbH Corporation Information
6.3.2 TissUse GmbH Description and Business Overview
6.3.3 TissUse GmbH Human Tissue Chips Sales, Revenue and Gross Margin (2018-2023)
6.3.4 TissUse GmbH Human Tissue Chips Product Portfolio
6.3.5 TissUse GmbH Recent Developments/Updates
6.4 InSphero AG
6.4.1 InSphero AG Corporation Information
6.4.2 InSphero AG Description and Business Overview
6.4.3 InSphero AG Human Tissue Chips Sales, Revenue and Gross Margin (2018-2023)
6.4.4 InSphero AG Human Tissue Chips Product Portfolio
6.4.5 InSphero AG Recent Developments/Updates
6.5 HµRel Corporation
6.5.1 HµRel Corporation Corporation Information
6.5.2 HµRel Corporation Description and Business Overview
6.5.3 HµRel Corporation Human Tissue Chips Sales, Revenue and Gross Margin (2018-2023)
6.5.4 HµRel Corporation Human Tissue Chips Product Portfolio
6.5.5 HµRel Corporation Recent Developments/Updates
6.6 AxoSim Technologies LLC
6.6.1 AxoSim Technologies LLC Corporation Information
6.6.2 AxoSim Technologies LLC Description and Business Overview
6.6.3 AxoSim Technologies LLC Human Tissue Chips Sales, Revenue and Gross Margin (2018-2023)
6.6.4 AxoSim Technologies LLC Human Tissue Chips Product Portfolio
6.6.5 AxoSim Technologies LLC Recent Developments/Updates
6.7 Kugelmeiers Ltd.
6.6.1 Kugelmeiers Ltd. Corporation Information
6.6.2 Kugelmeiers Ltd. Description and Business Overview
6.6.3 Kugelmeiers Ltd. Human Tissue Chips Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Kugelmeiers Ltd. Human Tissue Chips Product Portfolio
6.7.5 Kugelmeiers Ltd. Recent Developments/Updates
6.8 Miroculus Inc.
6.8.1 Miroculus Inc. Corporation Information
6.8.2 Miroculus Inc. Description and Business Overview
6.8.3 Miroculus Inc. Human Tissue Chips Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Miroculus Inc. Human Tissue Chips Product Portfolio
6.8.5 Miroculus Inc. Recent Developments/Updates
6.9 Mimetas BV
6.9.1 Mimetas BV Corporation Information
6.9.2 Mimetas BV Description and Business Overview
6.9.3 Mimetas BV Human Tissue Chips Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Mimetas BV Human Tissue Chips Product Portfolio
6.9.5 Mimetas BV Recent Developments/Updates
6.10 SynVivo Inc.
6.10.1 SynVivo Inc. Corporation Information
6.10.2 SynVivo Inc. Description and Business Overview
6.10.3 SynVivo Inc. Human Tissue Chips Sales, Revenue and Gross Margin (2018-2023)
6.10.4 SynVivo Inc. Human Tissue Chips Product Portfolio
6.10.5 SynVivo Inc. Recent Developments/Updates
6.11 Advanced BioMatrix Inc.
6.11.1 Advanced BioMatrix Inc. Corporation Information
6.11.2 Advanced BioMatrix Inc. Human Tissue Chips Description and Business Overview
6.11.3 Advanced BioMatrix Inc. Human Tissue Chips Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Advanced BioMatrix Inc. Human Tissue Chips Product Portfolio
6.11.5 Advanced BioMatrix Inc. Recent Developments/Updates
6.12 BIOMIMESYS
6.12.1 BIOMIMESYS Corporation Information
6.12.2 BIOMIMESYS Human Tissue Chips Description and Business Overview
6.12.3 BIOMIMESYS Human Tissue Chips Sales, Revenue and Gross Margin (2018-2023)
6.12.4 BIOMIMESYS Human Tissue Chips Product Portfolio
6.12.5 BIOMIMESYS Recent Developments/Updates
6.13 Tara Biosystems, Inc.
6.13.1 Tara Biosystems, Inc. Corporation Information
6.13.2 Tara Biosystems, Inc. Human Tissue Chips Description and Business Overview
6.13.3 Tara Biosystems, Inc. Human Tissue Chips Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Tara Biosystems, Inc. Human Tissue Chips Product Portfolio
6.13.5 Tara Biosystems, Inc. Recent Developments/Updates
6.14 V&F Bioprocessing, Inc.
6.14.1 V&F Bioprocessing, Inc. Corporation Information
6.14.2 V&F Bioprocessing, Inc. Human Tissue Chips Description and Business Overview
6.14.3 V&F Bioprocessing, Inc. Human Tissue Chips Sales, Revenue and Gross Margin (2018-2023)
6.14.4 V&F Bioprocessing, Inc. Human Tissue Chips Product Portfolio
6.14.5 V&F Bioprocessing, Inc. Recent Developments/Updates
6.15 Xylyx Bio, Inc.
6.15.1 Xylyx Bio, Inc. Corporation Information
6.15.2 Xylyx Bio, Inc. Human Tissue Chips Description and Business Overview
6.15.3 Xylyx Bio, Inc. Human Tissue Chips Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Xylyx Bio, Inc. Human Tissue Chips Product Portfolio
6.15.5 Xylyx Bio, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Tissue Chips Industry Chain Analysis
7.2 Human Tissue Chips Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Tissue Chips Production Mode & Process
7.4 Human Tissue Chips Sales and Marketing
7.4.1 Human Tissue Chips Sales Channels
7.4.2 Human Tissue Chips Distributors
7.5 Human Tissue Chips Customers
8 Human Tissue Chips Market Dynamics
8.1 Human Tissue Chips Industry Trends
8.2 Human Tissue Chips Market Drivers
8.3 Human Tissue Chips Market Challenges
8.4 Human Tissue Chips Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’